CD40 and melanoma: Combining agonistic CD40 mAb with epacadostat significantly prolonged survival of B16-F10 melanoma bearing mice as compared to control and epacadostat alone, while there was no significant difference in survival between mice treated with agonistic CD40 mAb and the combination (Figure 6a).